Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2013
Setting up and monitoring an infection of Dictyostelium discoideum with mycobacteriaSonia Arafah, Sébastien Kicka, Valentin Trofimov, et al.Scientific Reports|February 9, 2017
Primary macrophages and J774 cells respond differently to infection with Mycobacterium tuberculosisNuria Andreu, Jody Phelan, Paola F de Sessions, et al.BMC Genomics|November 8, 2015
Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA spongesXavier Bofill-De Ros, Mónica Santos, Maria Vila-Casadesús, et al.Blood Cells, Molecules & Diseases|November 26, 2003
Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivationNuria Andreu, Núria Pujol-Moix, Luis Martinez-Lostao, et al.The Journal of Antimicrobial Chemotherapy|May 2, 2013
Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferaseNuria Andreu, Andrea Zelmer, Samantha L Sampson, et al.Vaccine|April 15, 2015
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion systemDaria Bottai, Wafa Frigui, Simon Clark, et al.Plos One|June 4, 2010
Optimisation of bioluminescent reporters for use with mycobacteriaNuria Andreu, Andrea Zelmer, Taryn Fletcher, et al.Scientific Reports|March 28, 2019
An integrated whole genome analysis of Mycobacterium tuberculosis reveals insights into relationship between its genome, transcriptome and methylomePaula J Gomez-Gonzalez, Nuria Andreu, Jody E Phelan, et al.The Journal of Antimicrobial Chemotherapy|May 29, 2012
A new in vivo model to test anti-tuberculosis drugs using fluorescence imagingAndrea Zelmer, Paul Carroll, Nuria Andreu, et al.Journal of Oral Microbiology|January 18, 2021
Oral microbiome in down syndrome and its implications on oral healthJesse R Willis, Susana Iraola-Guzmán, Ester Saus, et al.Pageof 3